Developing the Manufacturer’s Playbook for Product Launches in Canada

Canada currently has the longest wait times in the G-7 for access to new medications.  On top of the lengthy Canadian approval process, global economic uncertainty adds further uncertainty to launch prospects.  Gain key insights into how manufacturers are navigating this whitewater environment so you can:

• Gain clarity on how Canadian policies and market access is different from other G-7 countries
• What avenues are potentially available to improve time to market
• Develop your strategy for timing and executing your launch with greater confidence
• Determine how best to co-ordinate the launch of drugs with companion devices

Confidently navigate today’s turbulence to develop successful launch strategies.